Mount Yale Investment Advisors LLC Sells 128 Shares of The Cigna Group (NYSE:CI)

Mount Yale Investment Advisors LLC decreased its position in The Cigna Group (NYSE:CI) by 7.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,608 shares of the health services provider’s stock after selling 128 shares during the quarter. Mount Yale Investment Advisors LLC’s holdings in The Cigna Group were worth $584,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Seizert Capital Partners LLC increased its holdings in The Cigna Group by 195.8% in the 4th quarter. Seizert Capital Partners LLC now owns 32,150 shares of the health services provider’s stock valued at $9,627,000 after buying an additional 21,280 shares during the period. Roman Butler Fullerton & Co. increased its stake in The Cigna Group by 61.4% in the fourth quarter. Roman Butler Fullerton & Co. now owns 9,307 shares of the health services provider’s stock valued at $2,772,000 after acquiring an additional 3,539 shares during the last quarter. TFO Wealth Partners LLC raised its position in The Cigna Group by 98,980.0% during the fourth quarter. TFO Wealth Partners LLC now owns 4,954 shares of the health services provider’s stock valued at $1,497,000 after purchasing an additional 4,949 shares in the last quarter. Sapient Capital LLC bought a new stake in The Cigna Group during the fourth quarter worth $2,811,000. Finally, Allspring Global Investments Holdings LLC boosted its holdings in shares of The Cigna Group by 29.5% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 293,438 shares of the health services provider’s stock valued at $87,870,000 after purchasing an additional 66,891 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Stock Up 2.2 %

CI stock traded up $7.53 during mid-day trading on Tuesday, reaching $354.07. 155,205 shares of the company traded hands, compared to its average volume of 1,550,180. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.75. The firm’s 50 day moving average price is $335.24 and its 200 day moving average price is $338.14. The stock has a market cap of $100.58 billion, a price-to-earnings ratio of 28.46, a P/E/G ratio of 1.05 and a beta of 0.52. The Cigna Group has a fifty-two week low of $253.95 and a fifty-two week high of $365.71.

The Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, May 2nd. The health services provider reported $6.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.17 by $0.30. The Cigna Group had a return on equity of 17.24% and a net margin of 1.76%. The business had revenue of $57.25 billion during the quarter, compared to the consensus estimate of $56.59 billion. During the same quarter in the prior year, the company posted $5.41 earnings per share. The Cigna Group’s revenue was up 23.2% compared to the same quarter last year. As a group, equities research analysts predict that The Cigna Group will post 28.47 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 19th. Investors of record on Wednesday, September 4th will be issued a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a yield of 1.58%. The ex-dividend date is Wednesday, September 4th. The Cigna Group’s dividend payout ratio (DPR) is presently 45.98%.

Wall Street Analysts Forecast Growth

CI has been the topic of a number of recent analyst reports. StockNews.com cut The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 20th. JPMorgan Chase & Co. raised their price target on shares of The Cigna Group from $432.00 to $435.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Robert W. Baird assumed coverage on shares of The Cigna Group in a research note on Thursday, May 30th. They issued an “outperform” rating and a $388.00 price objective on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $400.00 target price on shares of The Cigna Group in a research report on Wednesday, July 10th. Finally, Piper Sandler began coverage on The Cigna Group in a research report on Wednesday, June 26th. They issued an “overweight” rating and a $400.00 price target on the stock. Two analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $376.20.

Insider Buying and Selling at The Cigna Group

In other The Cigna Group news, insider Noelle K. Eder sold 10,700 shares of the business’s stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $348.47, for a total value of $3,728,629.00. Following the transaction, the insider now directly owns 15,824 shares in the company, valued at $5,514,189.28. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, insider Noelle K. Eder sold 10,700 shares of the company’s stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of $348.47, for a total value of $3,728,629.00. Following the transaction, the insider now owns 15,824 shares in the company, valued at $5,514,189.28. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Elder Granger sold 547 shares of the stock in a transaction on Monday, June 17th. The shares were sold at an average price of $331.38, for a total value of $181,264.86. Following the transaction, the director now directly owns 5,471 shares of the company’s stock, valued at $1,812,979.98. The disclosure for this sale can be found here. In the last 90 days, insiders sold 22,988 shares of company stock worth $7,975,726. Insiders own 0.60% of the company’s stock.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.